MAPT and Alzheimer disease: It is the most studied network and is thought to be the first network with the risk of damage during AD because it is more susceptible to β-amyloid and tau deposition and glucose hypometabolism, which positions it as an early target in AD pathogenesis (Chiesa et al., 2019; Ingala et al., 2021).